The American Association of Cancer Researchers (AACR) is in the midst of its annual scientific research meeting in Denver Colorado. As interesting prostate cancer specific information becomes available I will try and share the news. One of the biggest concerns we face in prostate cancer is in deciding when a cancer needs to be treated. [...]
A phase II trial was just completed at the University of Western Australia to investigate changes in bone mineral density (BMD) and osteoporosis in men on intermittent androgen-suppression therapy (IAST) over a period of three years. This trial, conducted at the Faculty of Medicine, University of Western Australia, Crawley, Department of Radiation Oncology, Sir Charles [...]
Under the resources section of the blog I have just added the Memorial Sloan-Kettering Cancer Center prostate nomogram for PSA doubling and PSA velocity. Joel T Nowak MA, MSW
Vickie wrote both a very moving and very important email to the "circle" mailing list. After reading this post I contacted her to asked permission to repost it on this blog. I am very thankful to her for giving me permission to re-publish it and I am hopeful that she will continue to share her [...]
A recent report from England, about the first-generation oral bisphosphonate sodium clodronate, claims to improve overall survival in men with metastatic but not localized prostate cancer, according to long-term data from two randomized controlled trials. Among the sample of 278 men all who had metastatic disease starting and who were responding to long-term hormone therapy, [...]